• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全面分析 HOXA 基因家族发现 HOXA13 是肾透明细胞癌中的一个新的致癌基因。

Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.

机构信息

Department of Translational Medicine Center, Zhengzhou Central Hospital Affiliated To Zhengzhou University, Zhengzhou, 450007, China.

School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.

出版信息

J Cancer Res Clin Oncol. 2020 Aug;146(8):1993-2006. doi: 10.1007/s00432-020-03259-x. Epub 2020 May 22.

DOI:10.1007/s00432-020-03259-x
PMID:32444962
Abstract

OBJECTIVES

Kidney renal clear cell carcinoma (KIRC) is one of the most common lethal cancers in the human urogenital system. As members of the Homeobox (HOX) family, Homeobox-A (HOXA) cluster genes have been reported to be involved in the development of many cancer types. However, the expression and clinical significance of HOXA genes in KIRC remain largely unknown.

MATERIALS AND METHODS

In this study, we comprehensively analyzed the mRNA expression and prognostic values of HOXA genes in KIRC using The Cancer Genome Atlas (TCGA) analysis databases online. Colony formation assay, flow cytometry and Western blot were used to detect cell proliferation, apoptosis, cell cycle, and protein level of the indicated gene.

RESULTS

We found that the HOXA genes were differentially expressed in KIRC tissues when compared with normal tissues. The expression of HOXA4 and HOXA13 were significantly up-regulated, while HOXA7 and HOXA11 were down-regulated in KIRC. High mRNA levels of HOXA2, HOXA3 and HOXA13, and low level of HOXA7 predicted poor overall survival (OS) of KIRC patients. High mRNA level of HOXA13 further indicated a poor disease-free survival (DFS) of KIRC patients. Functionally, knockdown of HOXA13 significantly suppressed cell proliferation of KIRC in vitro, increased the protein level of p53 and decreased the protein level of cyclin D1 in KIRC cells. Over-expression of HOXA13 had the opposite effects on KIRC cells.

CONCLUSION

Collectively, our findings suggest that HOXA13 functions as a novel oncogene in KIRC and may be a potential biomarker for this malignancy.

摘要

目的

肾透明细胞癌(KIRC)是人类泌尿生殖系统中最常见的致命癌症之一。作为同源盒(HOX)家族的成员,已报道同源盒-A(HOXA)簇基因参与多种癌症类型的发展。然而,HOXA 基因在 KIRC 中的表达和临床意义在很大程度上仍不清楚。

材料和方法

本研究通过在线分析癌症基因组图谱(TCGA)分析数据库,全面分析了 HOXA 基因在 KIRC 中的 mRNA 表达和预后价值。集落形成实验、流式细胞术和 Western blot 用于检测细胞增殖、凋亡、细胞周期和指示基因的蛋白水平。

结果

我们发现 HOXA 基因在 KIRC 组织中与正常组织相比存在差异表达。HOXA4 和 HOXA13 的表达明显上调,而 HOXA7 和 HOXA11 在 KIRC 中下调。HOXA2、HOXA3 和 HOXA13 的高 mRNA 水平和 HOXA7 的低水平预示着 KIRC 患者的总体生存率(OS)较差。HOXA13 的高 mRNA 水平进一步表明 KIRC 患者的无病生存率(DFS)较差。功能上,HOXA13 的敲低显著抑制了 KIRC 的体外细胞增殖,增加了 KIRC 细胞中 p53 的蛋白水平并降低了细胞周期蛋白 D1 的蛋白水平。HOXA13 的过表达对 KIRC 细胞产生了相反的影响。

结论

综上所述,我们的研究结果表明 HOXA13 作为 KIRC 的一种新型癌基因发挥作用,并且可能是这种恶性肿瘤的潜在生物标志物。

相似文献

1
Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.全面分析 HOXA 基因家族发现 HOXA13 是肾透明细胞癌中的一个新的致癌基因。
J Cancer Res Clin Oncol. 2020 Aug;146(8):1993-2006. doi: 10.1007/s00432-020-03259-x. Epub 2020 May 22.
2
Exploring the prognostic role and expression patterns of FAM3A family genes in kidney renal clear cell carcinoma.探索FAM3A家族基因在肾透明细胞癌中的预后作用及表达模式。
Sci Rep. 2025 Jul 1;15(1):22397. doi: 10.1038/s41598-025-05658-x.
3
M6A methyltransferase ZC3H13-mediated downregulation of GPX4 mRNA stability inhibits the progression of kidney renal clear cell carcinoma (KIRC).m6A甲基转移酶ZC3H13介导的GPX4 mRNA稳定性下调抑制肾透明细胞癌(KIRC)进展。
Cell Immunol. 2025 Aug;414:104998. doi: 10.1016/j.cellimm.2025.104998. Epub 2025 Jun 19.
4
Development and Validation of Anoiki-Related Lncrna Signature Prediction Model for KIRC Prognosis.用于肾透明细胞癌预后的anoiki相关长链非编码RNA特征预测模型的开发与验证
Comb Chem High Throughput Screen. 2025;28(9):1524-1542. doi: 10.2174/0113862073271880231114100544.
5
Identification and Validation of a Prognostic Model Based on Tumour Necrosis Factor-Related mRNAs for Kidney Renal Clear Cell Carcinoma.基于肿瘤坏死因子相关mRNA的肾透明细胞癌预后模型的鉴定与验证
J Cell Mol Med. 2025 Jul;29(14):e70657. doi: 10.1111/jcmm.70657.
6
Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.大麻素受体2作为促进肾细胞癌预后和进展的新靶点。
J Cancer Res Clin Oncol. 2018 Jan;144(1):39-52. doi: 10.1007/s00432-017-2527-y. Epub 2017 Oct 9.
7
Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.长链非编码 RNA HOTTIP 通过调控 PI3K/Akt/Atg13 信号通路影响肾细胞癌的进展。
J Cancer Res Clin Oncol. 2019 Mar;145(3):573-588. doi: 10.1007/s00432-018-2808-0. Epub 2018 Dec 3.
8
Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma.口腔鳞状细胞癌中m6A/m1A/m5C/m7G/ac4C修饰基因的生物信息学鉴定与验证
BMC Cancer. 2025 Jul 1;25(1):1055. doi: 10.1186/s12885-025-14216-7.
9
IL1A: a novel prognostic biomarker and potential therapeutic target for renal clear cell carcinoma.白细胞介素1α:肾透明细胞癌的一种新型预后生物标志物及潜在治疗靶点。
Oncol Res. 2025 Jun 26;33(7):1739-1755. doi: 10.32604/or.2025.061978. eCollection 2025.
10
Systematic pan-cancer analysis identifies PKNOX1 as a potential prognostic and immunological biomarker and its functional validation.全癌系统分析确定PKNOX1为一种潜在的预后和免疫生物标志物及其功能验证。
Front Immunol. 2025 Jun 23;16:1533690. doi: 10.3389/fimmu.2025.1533690. eCollection 2025.

引用本文的文献

1
The HOX Gene Family's Role as Prognostic and Diagnostic Biomarkers in Hematological and Solid Tumors.HOX基因家族在血液系统肿瘤和实体瘤中作为预后和诊断生物标志物的作用。
Cancers (Basel). 2025 Jan 15;17(2):262. doi: 10.3390/cancers17020262.
2
Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis.脑膜孤立性纤维瘤细胞状态模拟脑血管发育和稳态。
Neuro Oncol. 2025 Jan 12;27(1):155-166. doi: 10.1093/neuonc/noae172.
3
Role of HOXA1-4 in the development of genetic and malignant diseases.HOXA1 - 4在遗传和恶性疾病发展中的作用。

本文引用的文献

1
LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling.长链非编码 RNA GMDS-AS1 通过调控 miR-96-5p/CYLD 信号通路抑制肺腺癌的发展。
Cancer Med. 2020 Feb;9(3):1196-1208. doi: 10.1002/cam4.2776. Epub 2019 Dec 20.
2
HOX Genes in High Grade Ovarian Cancer.高级别卵巢癌中的HOX基因
Cancers (Basel). 2019 Aug 3;11(8):1107. doi: 10.3390/cancers11081107.
3
HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer.HOXA10 诱导 BCL2 表达,抑制细胞凋亡,促进胃癌细胞增殖。
Biomark Res. 2024 Feb 5;12(1):18. doi: 10.1186/s40364-024-00569-x.
4
Hsa-microRNA-1249-3p/Homeobox A13 axis modulates the expression of β-catenin gene in human epithelial cells.Hsa-microRNA-1249-3p/同源盒 A13 轴调节人上皮细胞中β-连环蛋白基因的表达。
Sci Rep. 2023 Dec 18;13(1):22872. doi: 10.1038/s41598-023-49837-0.
5
Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.Gasdermin D在肾透明细胞癌中的表达及其对其生物学功能的影响。
Front Oncol. 2023 Jul 6;13:1163714. doi: 10.3389/fonc.2023.1163714. eCollection 2023.
6
Evidence Based on an Integrative Analysis of Multi-Omics Data on METTL7A as a Molecular Marker in Pan-Cancer.基于多组学生物学数据的综合分析,METTL7A 作为一种泛癌的分子标志物。
Biomolecules. 2023 Jan 18;13(2):195. doi: 10.3390/biom13020195.
7
A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma.在肾透明细胞癌中构建基于计算的 lncRNA 相关竞争性三重态网络。
Dis Markers. 2022 Nov 17;2022:8928282. doi: 10.1155/2022/8928282. eCollection 2022.
8
Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance.关于预后和免疫意义的透明细胞肾细胞癌中同源盒家族基因特征的综合分析。
Front Oncol. 2022 Oct 31;12:1008714. doi: 10.3389/fonc.2022.1008714. eCollection 2022.
9
MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma.MND1 作为一个潜在的预后生物标志物,与肾透明细胞癌的细胞周期和免疫浸润相关。
Aging (Albany NY). 2022 Sep 10;14(18):7416-7442. doi: 10.18632/aging.204280.
10
Expression Landscape and Functional Roles of HOXA4 and HOXA5 in Lung Adenocarcinoma.HOXA4 和 HOXA5 在肺腺癌中的表达景观和功能作用。
Int J Med Sci. 2022 Mar 6;19(3):572-587. doi: 10.7150/ijms.70445. eCollection 2022.
Cancer Med. 2019 Sep;8(12):5651-5661. doi: 10.1002/cam4.2440. Epub 2019 Jul 30.
4
Study of Promoter Methylation Patterns of HOXA2, HOXA5, and HOXA6 and Its Clinicopathological Characteristics in Colorectal Cancer.结直肠癌中HOXA2、HOXA5和HOXA6启动子甲基化模式及其临床病理特征的研究
Front Oncol. 2019 May 21;9:394. doi: 10.3389/fonc.2019.00394. eCollection 2019.
5
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.WebGestalt 2019:基因集分析工具包,具有全新的用户界面和 API。
Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205. doi: 10.1093/nar/gkz401.
6
Clonal architectures predict clinical outcome in clear cell renal cell carcinoma.克隆结构可预测肾透明细胞癌的临床结局。
Nat Commun. 2019 Mar 18;10(1):1245. doi: 10.1038/s41467-019-09241-7.
7
Elevated expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1/2.表达升高部分通过激活Erk1/2促进胃癌的增殖和转移。
Onco Targets Ther. 2019 Mar 4;12:1803-1813. doi: 10.2147/OTT.S196986. eCollection 2019.
8
Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.长链非编码 RNA ZFAS1 通过靶向 miR-10a/SKA1 通路促进肾透明细胞癌的增殖和转移。
Biomed Pharmacother. 2019 Mar;111:917-925. doi: 10.1016/j.biopha.2018.12.143. Epub 2019 Jan 7.
9
HOXA1 upregulation is associated with poor prognosis and tumor progression in breast cancer.HOXA1上调与乳腺癌的不良预后和肿瘤进展相关。
Exp Ther Med. 2019 Mar;17(3):1896-1902. doi: 10.3892/etm.2018.7145. Epub 2018 Dec 28.
10
HOXA10 expression profiling in prostate cancer.HOXA10 在前列腺癌中的表达谱分析。
Prostate. 2019 Apr;79(5):554-563. doi: 10.1002/pros.23761. Epub 2019 Jan 6.